Shingrix Effectiveness in Preventing Shingles in Seniors
A real-world analysis reveals that Shingrix is highly effective in preventing shingles in adults over 65, including those with compromised immune systems.
According to a study published in the Annals of Internal Medicine, two doses of Shingrix provide better protection against shingles than a single dose.
What is Shingles?
Shingles is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which is the same virus that causes chickenpox. It commonly presents as a rash with painful blisters across the chest, abdomen, or face.
Risk and Complications
While anyone can get shingles, it is more common in adults over 50, according to the CDC. A significant complication of shingles is post-herpetic neuralgia (PHN), a long-lasting nerve pain that can last weeks or months, affecting between 5% and 30% of patients.
About Shingrix
Shingrix is a recombinant zoster vaccine (RZV) manufactured by GSK, proven effective in preventing shingles in seniors, including those who are immunocompromised.
No direct quote available in the given text.
Author's summary: Shingrix prevents shingles in seniors.